Omeprazole serves as a foundational proton pump inhibitor that effectively diminishes gastric acid production by irreversibly binding to the $H^+/K^+$-ATPase enzyme system within the parietal cells. The capsule delivery format is specifically engineered with enteric-coated pellets to safeguard the acid-labile molecule from gastric degradation, ensuring its stable transit to the small intestine for optimal systemic absorption. This sophisticated formulation provides high bioavailability and sustained therapeutic concentrations, offering a reliable clinical solution for the management of hypersecretory conditions and the promotion of mucosal healing.

Reviews
There are no reviews yet.